177 related articles for article (PubMed ID: 17680635)
1. Residual disease after re-excision for tumour-positive surgical margins in both ductal carcinoma in situ and invasive carcinoma of the breast: The effect of time.
Schouten van der Velden AP; Van de Vrande SL; Boetes C; Bult P; Wobbes T
J Surg Oncol; 2007 Dec; 96(7):569-74. PubMed ID: 17680635
[TBL] [Abstract][Full Text] [Related]
2. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
3. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
4. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
[TBL] [Abstract][Full Text] [Related]
5. Review of re-excision for narrow or positive margins of invasive and intraductal carcinoma.
Gupta A; Subhas G; Dubay L; Silapaswan S; Kolachalam R; Kestenberg W; Ferguson L; Jacobs MJ; Gorieil Y; Mittal VK
Am Surg; 2010 Jul; 76(7):731-4. PubMed ID: 20698380
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting successful breast conservation for ductal carcinoma in situ.
Dillon MF; Mc Dermott EW; O'Doherty A; Quinn CM; Hill AD; O'Higgins N
Ann Surg Oncol; 2007 May; 14(5):1618-28. PubMed ID: 17443388
[TBL] [Abstract][Full Text] [Related]
7. A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery.
Ward ST; Jones BG; Jewkes AJ
Int J Clin Pract; 2010 Nov; 64(12):1675-80. PubMed ID: 20946273
[TBL] [Abstract][Full Text] [Related]
8. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
[TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for residual disease in re-excision specimens after breast-conserving surgery.
Atalay C; Irkkan C
Breast J; 2012; 18(4):339-44. PubMed ID: 22616572
[TBL] [Abstract][Full Text] [Related]
11. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
[TBL] [Abstract][Full Text] [Related]
12. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
Valdes EK; Boolbol SK; Cohen JM; Feldman SM
Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
[TBL] [Abstract][Full Text] [Related]
13. Predictors of re-excision among women undergoing breast-conserving surgery for cancer.
Waljee JF; Hu ES; Newman LA; Alderman AK
Ann Surg Oncol; 2008 May; 15(5):1297-303. PubMed ID: 18259820
[TBL] [Abstract][Full Text] [Related]
14. Factors predisposing to cavity margin positivity following conservation surgery for breast cancer.
Keskek M; Kothari M; Ardehali B; Betambeau N; Nasiri N; Gui GP
Eur J Surg Oncol; 2004 Dec; 30(10):1058-64. PubMed ID: 15522551
[TBL] [Abstract][Full Text] [Related]
15. Multiple re-excisions versus mastectomy in patients with persistent residual disease following breast conservation surgery.
Cellini C; Huston TL; Martins D; Christos P; Carson J; Kemper S; Simmons RM
Am J Surg; 2005 Jun; 189(6):662-6. PubMed ID: 15910716
[TBL] [Abstract][Full Text] [Related]
16. The relationship between shaved margin and inked margin status in breast excision specimens.
Guidi AJ; Connolly JL; Harris JR; Schnitt SJ
Cancer; 1997 Apr; 79(8):1568-73. PubMed ID: 9118040
[TBL] [Abstract][Full Text] [Related]
17. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
[TBL] [Abstract][Full Text] [Related]
18. Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
Peintinger F; Kuerer HM; McGuire SE; Bassett R; Pusztai L; Symmans WF
Br J Surg; 2008 Apr; 95(4):433-7. PubMed ID: 18161887
[TBL] [Abstract][Full Text] [Related]
19. Involved anterior margins after breast conserving surgery: is re-excision required?
Mullen R; Macaskill EJ; Khalil A; Elseedawy E; Brown DC; Lee AC; Purdie CA; Jordan LB; Thompson AM
Eur J Surg Oncol; 2012 Apr; 38(4):302-6. PubMed ID: 22285907
[TBL] [Abstract][Full Text] [Related]
20. Experience with the Advanced Breast Biopsy Instrumentation (ABBI) system.
Watermann DO; Einert A; Ehritt-Braun C; Hasenburg A; Kieback DG
Anticancer Res; 2002; 22(5):3067-70. PubMed ID: 12530044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
